Actively Recruiting
Comparing the Efficacy of Combined Behavioral Intervention and Ericksonian Hypnotherapy in the Treatment of Alcohol Addiction: A Randomized Controlled Trial
Led by Beykoz University · Updated on 2025-04-16
90
Participants Needed
1
Research Sites
11 weeks
Total Duration
On this page
Sponsors
B
Beykoz University
Lead Sponsor
I
Istanbul Nisantasi University
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating two psychological treatments for adults with Alcohol Use Disorder (AUD) to see which better helps reduce alcohol consumption and improve mental health. The study compares Combined Behavioral Intervention (CBI), a structured approach using motivational interviewing, cognitive behavioral therapy, and relapse prevention, with Ericksonian Hypnotherapy (EH), a personalized method using trance and metaphor. A third group will receive educational materials without therapy to serve as a control. The goal is to find out which therapy works best, for whom, and under what conditions. Participants will be randomly assigned to one of three groups: weekly CBI sessions lasting about 60 minutes, weekly EH sessions lasting 45 to 60 minutes, or a control group receiving psychoeducational brochures and referral information. Both active treatments involve 12 weekly sessions, with CBI focusing on conscious skills and EH using hypnotic techniques and personalized suggestions. The control group will not receive structured therapy but will complete the same assessments as the other groups. Participants will be assessed at four points: before treatment, mid-treatment at 6 weeks, post-treatment at 12 weeks, and a 3-month follow-up. Researchers will track changes in alcohol use with the Timeline Follow-Back method and measure cravings, depression, anxiety, quality of life, and motivation to change using validated questionnaires. Attendance and satisfaction with therapy will also be monitored. The study will analyze differences between groups over time to evaluate the effects of the therapies and follow participants until February 2026.
CONDITIONS
Brief Title
Comparing Combined Behavioral Intervention and Ericksonian Hypnotherapy for Alcohol Addiction
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged between 18 and 65 years
- Meets DSM-5 diagnostic criteria for Alcohol Use Disorder (mild to severe)
- Medically and psychiatrically stable as determined by a clinician
- Willing and able to participate in weekly sessions over a 12-week period
- Provides informed consent
You will not qualify if you...
- Current diagnosis of a severe psychiatric disorder (e.g., psychotic disorder, bipolar I disorder)
- Significant cognitive impairment that would interfere with treatment participation
- Participation in another structured addiction treatment during the study period
- Current use of psychotropic medications that may influence outcome measures (as assessed by the clinical team)
- Unstable medical condition requiring immediate intervention
- Pregnancy or planning to become pregnant during the study period
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 12 weeks
Participants receive 12 weekly sessions of either Combined Behavioral Intervention or Ericksonian Hypnotherapy. The Combined Behavioral Intervention involves structured therapy sessions including motivational interviewing, cognitive behavioral therapy, and relapse prevention strategies. Ericksonian Hypnotherapy uses individualized trance induction, therapeutic metaphors, and ego-strengthening techniques. Participants in the control group receive educational materials and referral information but no structured therapy.
Weekly visits for 12 weeks
Duration - Approximately 7.5 months
Participants are monitored to assess changes in alcohol consumption, craving, mental health symptoms, quality of life, and readiness to change up to 10 months after treatment completion.
1 visit at Month 10 post-treatment
Trial Site Locations
Total: 1 location
1
Beykoz University
Istanbul, Turkey (Türkiye), 34820
Actively Recruiting
Research Team
E
Eda Yılmazer, Phd
M
Metin Çınaroğlu, Phd
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here